Education
About Us
Working with TipRanks
Follow Us
Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
RESEARCH TOOLSreports
Total Valuation
Medexus Pharmaceuticals Inc has a market cap or net worth of C$90.65M. The enterprise value is C$79.07M.
Market CapC$90.65M
Enterprise ValueC$79.07M
Share Statistics
Medexus Pharmaceuticals Inc has 32,258,354 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,258,354
Owned by Insiders7.36%
Owned by Institutions0.03%
Financial Efficiency
Medexus Pharmaceuticals Inc’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 11.51%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.01
Return on Invested Capital (ROIC)11.51%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.32M
Profits Per Employee27.40K
Employee Count82
Asset Turnover0.63
Inventory Turnover1.47
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio21.9
PS Ratio0.00
PB Ratio-1.92
Price to Fair Value0.83
Price to FCF3.17
Price to Operating Cash Flow-4.16
PEG Ratio1.02
Income Statement
In the last 12 months, Medexus Pharmaceuticals Inc had revenue of 108.33M and earned 2.25M in profits. Earnings per share was 0.09.
Revenue108.33M
Gross Profit56.58M
Operating Income8.22M
Pretax Income1.44M
Net Income2.25M
EBITDA16.81M
Earnings Per Share (EPS)0.09
Cash Flow
In the last 12 months, operating cash flow was 24.03M and capital expenditures -2.73M, giving a free cash flow of 21.31M billion.
Operating Cash Flow24.03M
Free Cash Flow21.31M
Free Cash Flow per Share0.66
Dividends & Yields
Medexus Pharmaceuticals Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.70
52-Week Price Change27.15%
50-Day Moving Average2.93
200-Day Moving Average2.88
Relative Strength Index (RSI)44.31
Average Volume (3m)39.70K
Important Dates
Medexus Pharmaceuticals Inc upcoming earnings date is Aug 6, 2025, Before Open (Confirmed).
Last Earnings DateJun 25, 2025
Next Earnings DateAug 6, 2025
Ex-Dividend Date―
Financial Position
Medexus Pharmaceuticals Inc as a current ratio of 0.83, with Debt / Equity ratio of 71.30%
Current Ratio0.83
Quick Ratio0.47
Debt to Market Cap0.86
Net Debt to EBITDA0.79
Interest Coverage Ratio1.00
Taxes
In the past 12 months, Medexus Pharmaceuticals Inc has paid -807.00K in taxes.
Income Tax-807.00K
Effective Tax Rate-0.56
Enterprise Valuation
Medexus Pharmaceuticals Inc EV to EBITDA ratio is 3.37, with an EV/FCF ratio of 2.66.
EV to Sales0.52
EV to EBITDA3.37
EV to Free Cash Flow2.66
EV to Operating Cash Flow2.36
Balance Sheet
Medexus Pharmaceuticals Inc has C$23.97M in cash and marketable securities with $37.18M in debt, giving a net cash position of C$13.21M billion.
Cash & Marketable SecuritiesC$23.97M
Total Debt$37.18M
Net CashC$13.21M
Net Cash Per ShareC$0.41
Tangible Book Value Per Share-C$1.14
Margins
Gross margin is 52.23%, with operating margin of 7.59%, and net profit margin of 2.07%.
Gross Margin52.23%
Operating Margin7.59%
Pretax Margin1.33%
Net Profit Margin2.07%
EBITDA Margin15.52%
EBIT Margin8.89%
Analyst Forecast
The average price target for Medexus Pharmaceuticals Inc is C$6.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetC$6.67
Price Target Upside137.37% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast-1.14%
EPS Growth Forecast―